Concerns for the Methodology and Results Described in "Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life"

Affiliations

¹ Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts; Division of Critical Care Medicine, Department of Medicine, St. Paul's Hospital, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada.
² Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts; Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Canada.

Comment

Barret Rush et al. Clin Gastroenterol Hepatol. 2017 Oct.

. 2017 Oct;15(10):1641-1642.

doi: 10.1016/j.cgh.2017.04.003. Epub 2017 Apr 7.

¹ Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts; Division of Critical Care Medicine, Department of Medicine, St. Paul's Hospital, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada.
² Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts; Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Canada.

No abstract available

Comment in

Reply.
Patel A, Walling A, Wenger N. Patel A, et al. Clin Gastroenterol Hepatol. 2017 Oct;15(10):1642-1643. doi: 10.1016/j.cgh.2017.07.005. Epub 2017 Jul 12. Clin Gastroenterol Hepatol. 2017. PMID: 28711689 Free PMC article. No abstract available.

Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life.
Patel AA, Walling AM, Ricks-Oddie J, May FP, Saab S, Wenger N. Patel AA, et al. Clin Gastroenterol Hepatol. 2017 Oct;15(10):1612-1619.e4. doi: 10.1016/j.cgh.2017.01.030. Epub 2017 Feb 4. Clin Gastroenterol Hepatol. 2017. PMID: 28179192 Free PMC article.